Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Beilong Eucommia Biological Engineering is a Chinese biotechnology company specializing in the comprehensive development and industrialization of Eucommia ulmoides, a traditional medicinal plant. The company focuses on extracting high-value components such as Eucommia rubber (gutta-percha), seed oil, and bioactive compounds for use in healthcare, functional foods, and industrial applications. Their operations encompass the entire value chain from cultivation and extraction to the manufacturing of health supplements and pharmaceutical intermediates. By leveraging advanced biological engineering techniques, the company aims to modernize the application of Eucommia-derived products for cardiovascular and bone health. The company is recognized for its large-scale production capabilities and its contribution to the sustainable utilization of forest resources in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Beilong Eucommia Biological Engineering.